Last reviewed · How we verify
NCT07000851: I-CAN
Imaging Studies in Corticobasal Syndrome
trial testing C-11 ER176 Radiotracer in Cortico Basal Degeneration in 80 participants. Currently enrolling.
30 March 2030
Quick facts
| Lead sponsor | Jennifer Whitwell |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 25 June 2025 |
| Primary completion | 30 March 2030 |
| Estimated completion | 30 March 2031 |
| Sites | 1 location across United States |
Drugs / interventions tested
- C-11 ER176 Radiotracer — full drug profile →
- C-11 PiB — full drug profile →
- AV1451 Tau — full drug profile →
Conditions studied
- Cortico Basal Degeneration — all drugs for Cortico Basal Degeneration →
- Corticobasal Syndrome — all drugs for Corticobasal Syndrome →
- Corticobasal Syndrome(CBS) — all drugs for Corticobasal Syndrome(CBS) →
- Corticobasal Degeneration — all drugs for Corticobasal Degeneration →
Sponsor
Jennifer Whitwell
Who can join
18 and older, any sex, with Cortico Basal Degeneration or Corticobasal Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07000851
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cortico Basal Degeneration
Currently open trials in the same condition.
- NCT06645626 — Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07000851 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jennifer Whitwell
- Last refreshed: 7 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000851.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing